Author

S. Grueschow

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Organism:bacteria (other)· 1 Approach:biophysical modeling· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

C. Rouillon· 2 shared J. S. Athukoralage· 2 shared M. F. White· 2 shared S. Graham· 2 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

C. Rouillon

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A type III CRISPR ancillary ribonuclease degrades its cyclic oligoadenylate activator

J. S. Athukoralage, S. Graham, S. Grueschow, C. Rouillon, M. F. White

The paper identifies TTHB144 as a self-limiting CRISPR ribonuclease that degrades its cyclic oligoadenylate activator, providing a mechanism to terminate RNA degradation after viral infection.

bioRxiv · Mar 20, 2019Biochemistry

Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate

J. S. Athukoralage, C. Rouillon, S. Graham, S. Grueschow, M. F. White

The paper identifies a Ring nuclease that degrades cyclic oligoadenylate (cOA) to deactivate Type III CRISPR ribonucleases and terminate the antiviral state.

bioRxiv · Jul 30, 2018Biochemistry